PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?
Drug Discov Today Ther Strateg. 2007;4(1):93-99.
doi: 10.1016/j.ddstr.2007.10.006.
1 Departments of Medicine and Pharmacology, Renal Research Institute, New York Medical College, Valhalla, NY and Department of Pharmacology, Weill Medical College at Cornell University, New York, NY.